{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T02:29:13Z","timestamp":1783477753764,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T00:00:00Z","timestamp":1643241600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T00:00:00Z","timestamp":1643241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2018YFA 0800801"],"award-info":[{"award-number":["2018YFA 0800801"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"name":"CAMS Innovation Fund for Medical Sciences","award":["2016-I2M-3-003"],"award-info":[{"award-number":["2016-I2M-3-003"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970757"],"award-info":[{"award-number":["81970757"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s00198-021-06221-w","type":"journal-article","created":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T20:58:15Z","timestamp":1643317095000},"page":"1385-1395","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["The efficacy and safety of different doses of calcitriol combined with neutral phosphate in X-linked hypophosphatemia: a prospective study"],"prefix":"10.1007","volume":"33","author":[{"given":"C.","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Jiajue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7768-5536","authenticated-orcid":false,"given":"W.","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,27]]},"reference":[{"issue":"2","key":"6221_CR1","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/ng1095-130","volume":"11","author":"A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets","year":"1995","unstructured":"A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets (1995) The HYP Consortium Nat Genet 11(2):130\u20136","journal-title":"The HYP Consortium Nat Genet"},{"key":"6221_CR2","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1146\/annurev.med.051308.111339","volume":"61","author":"C Bergwitz","year":"2010","unstructured":"Bergwitz C, Juppner H (2010) Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23. Annu Rev Med 61:91\u2013104","journal-title":"Annu Rev Med"},{"issue":"1","key":"6221_CR3","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13023-019-1014-8","volume":"14","author":"SS Beck-Nielsen","year":"2019","unstructured":"Beck-Nielsen SS, Mughal Z, Haffner D et al (2019) FGF23 and its role in X-linked hypophosphatemia-related morbidity. Orphanet J Rare Dis 14(1):58","journal-title":"Orphanet J Rare Dis"},{"issue":"212","key":"6221_CR4","first-page":"20","volume":"121","author":"C Zhang","year":"2019","unstructured":"Zhang C, Zhao Z, Sun Y et al (2019) Clinical and genetic analysis in a large Chinese cohort of patients with X-linked hypophosphatemia. Bone 121(212):20","journal-title":"Bone"},{"issue":"8","key":"6221_CR5","doi-asserted-by":"publisher","first-page":"3591","DOI":"10.1210\/jc.2003-030036","volume":"88","author":"O Makitie","year":"2003","unstructured":"Makitie O, Doria A, Kooh SW et al (2003) Early treatment improves growth and biochemical and radiographic outcome in X-linked hypophosphatemic rickets. J Clin Endocrinol Metab 88(8):3591\u20133597","journal-title":"J Clin Endocrinol Metab"},{"issue":"18","key":"6221_CR6","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1056\/NEJM198010303031802","volume":"303","author":"FH Glorieux","year":"1980","unstructured":"Glorieux FH, Marie PJ, Pettifor JM et al (1980) Bone response to phosphate salts, ergocalciferol, and calcitriol in hypophosphatemic vitamin D-resistant rickets. N Engl J Med 303(18):1023\u20131031","journal-title":"N Engl J Med"},{"issue":"7","key":"6221_CR7","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1002\/jbmr.340","volume":"26","author":"TO Carpenter","year":"2011","unstructured":"Carpenter TO, Imel EA, Holm IA et al (2011) A clinician\u2019s guide to X-linked hypophosphatemia. J Bone Miner Res 26(7):1381\u20131388","journal-title":"J Bone Miner Res"},{"issue":"7","key":"6221_CR8","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41581-019-0152-5","volume":"15","author":"D Haffner","year":"2019","unstructured":"Haffner D, Emma F, Eastwood DM et al (2019) Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia. Nat Rev Nephrol 15(7):435\u2013455","journal-title":"Nat Rev Nephrol"},{"issue":"5","key":"6221_CR9","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1002\/jbmr.2783","volume":"31","author":"ES Liu","year":"2016","unstructured":"Liu ES, Martins JS, Raimann A et al (2016) 1,25-Dihydroxyvitamin D alone improves skeletal growth, microarchitecture, and strength in a murine model of XLH, despite enhanced FGF23 expression. J Bone Miner Res 31(5):929\u2013939","journal-title":"J Bone Miner Res"},{"issue":"21","key":"6221_CR10","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1056\/NEJMoa1714641","volume":"378","author":"TO Carpenter","year":"2018","unstructured":"Carpenter TO, Whyte MP, Imel EA et al (2018) Burosumab therapy in children with X-linked hypophosphatemia. N Engl J Med 378(21):1987\u20131998","journal-title":"N Engl J Med"},{"issue":"8","key":"6221_CR11","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1002\/jbmr.3475","volume":"33","author":"KL Insogna","year":"2018","unstructured":"Insogna KL, Briot K, Imel EA et al (2018) A randomized, double-blind, placebo-controlled, phase 3 Trial evaluating the efficacy of burosumab, an anti-FGF23 antibody, in adults with X-linked hypophosphatemia: week 24 primary analysis. J Bone Miner Res 33(8):1383\u20131393","journal-title":"J Bone Miner Res"},{"issue":"3","key":"6221_CR12","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S2213-8587(18)30338-3","volume":"7","author":"MP Whyte","year":"2019","unstructured":"Whyte MP, Carpenter TO, Gottesman GS et al (2019) Efficacy and safety of burosumab in children aged 1\u20134 years with X-linked hypophosphataemia: a multicentre, open-label, phase 2 trial. Lancet Diabetes Endocrinol 7(3):189\u2013199","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10189","key":"6221_CR13","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1016\/S0140-6736(19)30654-3","volume":"393","author":"EA Imel","year":"2019","unstructured":"Imel EA, Glorieux FH, Whyte MP et al (2019) Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial. Lancet 393(10189):2416\u20132427","journal-title":"Lancet"},{"issue":"3","key":"6221_CR14","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1093\/tropej\/46.3.132","volume":"46","author":"TD Thacher","year":"2000","unstructured":"Thacher TD, Fischer PR, Pettifor JM et al (2000) Radiographic scoring method for the assessment of the severity of nutritional rickets. J Trop Pediatr 46(3):132\u2013139","journal-title":"J Trop Pediatr"},{"issue":"76","key":"6221_CR15","first-page":"81","volume":"122","author":"TD Thacher","year":"2019","unstructured":"Thacher TD, Pettifor JM, Tebben PJ et al (2019) Rickets severity predicts clinical outcomes in children with X-linked hypophosphatemia: utility of the radiographic rickets severity score. Bone 122(76):81","journal-title":"Bone"},{"key":"6221_CR16","first-page":"487","volume":"47","author":"H LI","year":"2009","unstructured":"LI H, Cheng YJ, Zong XN, Zhang YQ (2009) Height and weight standardized growth charts for Chinese children and adolescents aged 0 to 18 years. Zhonghua Er Ke Za Zhi 47:487\u2013492","journal-title":"Zhonghua Er Ke Za Zhi"},{"issue":"1","key":"6221_CR17","doi-asserted-by":"publisher","first-page":"R13","DOI":"10.1530\/EC-13-0103","volume":"3","author":"A Linglart","year":"2014","unstructured":"Linglart A, Biosse-Duplan M, Briot K et al (2014) Therapeutic management of hypophosphatemic rickets from infancy to adulthood. Endocr Connect 3(1):R13-30","journal-title":"Endocr Connect"},{"issue":"3","key":"6221_CR18","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/S0022-3476(05)82822-7","volume":"116","author":"S Balsan","year":"1990","unstructured":"Balsan S, Tieder M (1990) Linear growth in patients with hypophosphatemic vitamin D-resistant rickets: influence of treatment regimen and parental height. J Pediatr 116(3):365\u2013371","journal-title":"J Pediatr"},{"issue":"4","key":"6221_CR19","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s00431-006-0357-z","volume":"166","author":"G Ariceta","year":"2007","unstructured":"Ariceta G, Langman CB (2007) Growth in X-linked hypophosphatemic rickets. Eur J Pediatr 166(4):303\u2013309","journal-title":"Eur J Pediatr"},{"issue":"10","key":"6221_CR20","doi-asserted-by":"publisher","first-page":"3625","DOI":"10.1210\/JC.2015-2199","volume":"100","author":"J Connor","year":"2015","unstructured":"Connor J, Olear EA, Insogna KL et al (2015) Conventional therapy in adults with X-linked hypophosphatemia: effects on enthesopathy and dental disease. J Clin Endocrinol Metab 100(10):3625\u20133632","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"6221_CR21","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1177\/0022034516677528","volume":"96","author":"M Biosseduplan","year":"2017","unstructured":"Biosseduplan M, Coyac BR, Bardet C et al (2017) Phosphate and vitamin D prevent periodontitis in X-linked hypophosphatemia. J Dent Res 96(4):388\u201395","journal-title":"J Dent Res"},{"issue":"Suppl 2","key":"6221_CR22","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s12325-019-01170-7","volume":"37","author":"P Arango sancho","year":"2020","unstructured":"Arango sancho P (2020) Complications of phosphate and vitamin D treatment in X-linked hypophosphataemia. Adv Ther 37(Suppl 2):105\u201312","journal-title":"Adv Ther"},{"issue":"2","key":"6221_CR23","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s00774-005-0656-x","volume":"24","author":"DH Su","year":"2006","unstructured":"Su DH, Liao KM, Chang YC et al (2006) Secondary hyperparathyroidism as a palpable intrathyroid parathyroid gland in a patient with hypophosphatemic osteomalacia. J Bone Miner Metab 24(2):114\u2013117","journal-title":"J Bone Miner Metab"},{"issue":"3","key":"6221_CR24","doi-asserted-by":"publisher","first-page":"294","DOI":"10.4158\/EP.12.3.294","volume":"12","author":"CR McHenry","year":"2006","unstructured":"McHenry CR, Mostafavi K, Murphy TA (2006) Tertiary hyperparathyroidism attributable to long-term oral phosphate therapy. Endocr Pract 12(3):294\u2013298","journal-title":"Endocr Pract"},{"key":"6221_CR25","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.bone.2019.06.025","volume":"127","author":"S Delacey","year":"2019","unstructured":"Delacey S, Liu Z, Broyles A et al (2019) Hyperparathyroidism and parathyroidectomy in X-linked hypophosphatemia patients. Bone 127:386\u201392","journal-title":"Bone"},{"issue":"1","key":"6221_CR26","doi-asserted-by":"publisher","first-page":"4693","DOI":"10.1038\/s41467-019-12399-9","volume":"10","author":"PP Centeno","year":"2019","unstructured":"Centeno PP, Herberger A, Mun HC et al (2019) Phosphate acts directly on the calcium-sensing receptor to stimulate parathyroid hormone secretion. Nat Commun 10(1):4693","journal-title":"Nat Commun"},{"issue":"5715","key":"6221_CR27","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1136\/bmj.3.5715.138","volume":"3","author":"JR Condon","year":"1970","unstructured":"Condon JR, Nassim JR, Rutter A (1970) Defective intestinal phosphate absorption in familial and non-familial hypophosphataemia. Br Med J 3(5715):138\u2013141","journal-title":"Br Med J"},{"key":"6221_CR28","unstructured":"WB. H X X, AL. E. 2009 Acute effects of oral phosphate-salt loading on serum phosphate and parathyroid hormone in hypophosphatemic rickets \/ osteomalacia. . ZhongHuaGuZhiShuSongYuGUKuangYanJiBing, 2(4): 243\u20138."},{"issue":"4","key":"6221_CR29","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1210\/jc.2009-1671","volume":"95","author":"EA Imel","year":"2010","unstructured":"Imel EA, Dimeglio LA, Hui SL et al (2010) Treatment of X-linked hypophosphatemia with calcitriol and phosphate increases circulating fibroblast growth factor 23 concentrations. J Clin Endocrinol Metab 95(4):1846\u20131850","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"6221_CR30","doi-asserted-by":"publisher","first-page":"145","DOI":"10.21873\/invivo.11038","volume":"31","author":"E Georgiadou","year":"2017","unstructured":"Georgiadou E, Marketou H, Trovas G et al (2017) Effect of calcitriol on FGF23 level in healthy adults and its dependence on phosphate level. In Vivo 31(1):145\u2013150","journal-title":"In Vivo"},{"issue":"8","key":"6221_CR31","doi-asserted-by":"publisher","first-page":"3144","DOI":"10.1210\/jc.2006-0021","volume":"91","author":"DM Antoniucci","year":"2006","unstructured":"Antoniucci DM, Yamashita T, Portale AA (2006) Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men. J Clin Endocrinol Metab 91(8):3144\u20133149","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-021-06221-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-021-06221-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-021-06221-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T10:05:20Z","timestamp":1652436320000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-021-06221-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,27]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["6221"],"URL":"https:\/\/doi.org\/10.1007\/s00198-021-06221-w","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,27]]},"assertion":[{"value":"7 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}